Clinical Trials Directory

Trials / Completed

CompletedNCT07113431

Partial-enteral Nutrition Protocol for Crohn's Disease

A Novel Partial-enteral Nutrition Protocol to Improve Nutrition Status of Adults Patients Experiencing a Crohn's Disease Flare and Starting New Immunologic Therapy.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Kate Farms Inc · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A novel dietary intervention combining a standardized IBD diet (IBD-AID) with supplementation from a pea protein plant-based oral nutrition supplement (ONS) (Kate Farms Peptide 1.5) to improve protein, calorie, and nutrient intake in adult patients experiencing a Crohn's disease flare starting new immunologic therapy. Additionally, this study will include objective measures of body composition to improve nutrition status assessment and provide a more sensitive measure of intervention efficacy compared to anthropometric measures of body weight or BMI.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTIBD-AID diet combined with Kate Farms Peptide 1.5Combining standardized-IBD diet developed by the University of Minnesota (IBD-AID) with commercially available pea protein plant-based enteral nutrition formula (Kate Farms Peptide 1.5)
OTHERIBD-AID dietStandardized IBD diet developed by the University of Massachusetts Medical School (IBD-AID)

Timeline

Start date
2023-08-01
Primary completion
2025-10-24
Completion
2025-10-24
First posted
2025-08-08
Last updated
2025-12-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07113431. Inclusion in this directory is not an endorsement.